Genta Incorporated is a biopharmaceutical company focused on the identification, development and commercialization of drugs for the treatment of people with cancer. We have built a broad portfolio of proprietary products in various stages of clinical development. Genta is committed to developing innovative products to better the lives of people with cancer.
Learn more about Genesense®, Genta’s late-stage pro-apoptotic drug
Genta is a team of smart, dedicated and high-energy individuals who appreciate a challenging entrepreneurial environment and who contribute daily to our company objectives. We are committed to aggressively leveraging our expertise in oncology drug development and commercialization.
Genta Incorporated is a biopharmaceutical company focused on the identification, development and commercialization of oncology drugs. Our strategy is to maximize shareholder value through excellence in performance and innovation, while maintaining the highest standards of integrity and leadership. Genta is committed to developing innovative products to better the lives of people with cancer.
Read More
Members of Genta’s Board of Directors have extensive medical, research, business, and pharmaceutical industry experience.
